Glucotrack annual return on equity
2006
2007
2008
2011
2012
2020
2021
2022
2023
Glucotrack Return on Equity (ROE) Growth & History (GCTK)
Glucotrack's return on equity was −320.62% for fiscal 2023.
View full Glucotrack company overviewGlucotrack annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | −320.62% | −181.70 pp |
| 2022 | 2022-12-31 | −138.92% | −81.38 pp |
| 2021 | 2021-12-31 | −57.54% | +13.69 pp |
| 2020 | 2020-12-31 | −71.23% | — |
| 2012 | 2012-12-31 | −1,191.95% | −890.07 pp |
| 2011 | 2011-12-31 | −301.89% | — |
| 2008 | 2008-12-31 | −516.58% | −379.14 pp |
| 2007 | 2007-12-31 | −137.44% | +32.91 pp |
| 2006 | 2006-12-31 | −170.34% | — |
Glucotrack quarterly return on equity
Q3.11
Q4.11
Q1.12
Q2.12
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | −438.44% | — |
| Q4 2025 | 2025-12-31 | −130.06% | — |
| Q3 2025 | 2025-09-30 | −86.62% | — |
| Q2 2025 | 2025-06-30 | −67.26% | — |
| Q1 2024 | 2024-03-31 | −163.89% | +43.37 pp |
| Q4 2023 | 2023-12-31 | −55.11% | +16.69 pp |
| Q3 2023 | 2023-09-30 | −33.43% | +0.04 pp |
| Q2 2023 | 2023-06-30 | −30.33% | +0.04 pp |
| Q1 2023 | 2023-03-31 | −207.25% | −183.96 pp |
| Q4 2022 | 2022-12-31 | −71.80% | −45.96 pp |
| Q3 2022 | 2022-09-30 | −33.47% | −21.81 pp |
| Q2 2022 | 2022-06-30 | −30.37% | −19.32 pp |
| Q1 2022 | 2022-03-31 | −23.29% | −12.74 pp |
| Q4 2021 | 2021-12-31 | −25.84% | −16.55 pp |
| Q3 2021 | 2021-09-30 | −11.66% | −6.67 pp |
| Q2 2021 | 2021-06-30 | −11.05% | −5.68 pp |
| Q1 2021 | 2021-03-31 | −10.55% | +4.84 pp |
| Q4 2020 | 2020-12-31 | −9.29% | — |
| Q3 2020 | 2020-09-30 | −5.00% | — |
| Q2 2020 | 2020-06-30 | −5.37% | — |
| Q1 2020 | 2020-03-31 | −15.40% | — |
| Q2 2012 | 2012-06-30 | −640.01% | — |
| Q1 2012 | 2012-03-31 | −91.72% | — |
| Q4 2011 | 2011-12-31 | −47.37% | — |
| Q3 2011 | 2011-09-30 | −65.69% | — |
Glucotrack return on equity trends
Between the periods ended 2006-12-31 and 2023-12-31, Glucotrack's return on equity decreased from −170.34% to −320.62%, a change of −150.28 percentage points. The latest reported quarter, Q1 2026, shows −438.44%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Glucotrack source filings ↗